UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

Frontiers in pharmacology, 2020-04, Vol.11, p.420

2020

Volltextzugriff (PDF)

A proposal for scientific framework enabling specific population drug dosing recommendations

Journal of clinical pharmacology, 2015-10, Vol.55 (10), p.1073-1078

2015

Volltextzugriff (PDF)

A comprehensive stability indicator for banks

Risks (Basel), 2020-03, Vol.8 (1), p.1-15

Powell, Robert

2020

Volltextzugriff (PDF)

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial

The New England journal of medicine, 2016-07, Vol.375 (4), p.390-391

2016

Volltextzugriff (PDF)

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

Clinical and translational science, 2020-07, Vol.13 (4), p.777-784

2020

Volltextzugriff (PDF)

Utility of Model‐Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS Workshop

Journal of clinical pharmacology, 2017-01, Vol.57 (1), p.105-109

2017

Volltextzugriff (PDF)

Drug Dosing Recommendations for All Patients: A Roadmap for Change

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.65-72

2021

Volltextzugriff (PDF)

Are new oral anticoagulant dosing recommendations optimal for all patients?

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (10), p.1013

Powell, J Robert

2015

Volltextzugriff (PDF)

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018

Clinical pharmacology and therapeutics, 2021-05, Vol.109 (5), p.1181-1181

2021

Volltextzugriff (PDF)

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial

The New England journal of medicine, 2016-07, Vol.375 (4), p.390

Powell, J Robert

2016

Volltextzugriff (PDF)

Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients

Clinical pharmacology and therapeutics, 2023-08, Vol.114 (2), p.362-370

2023

Volltextzugriff (PDF)

A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19

Clinical pharmacology and therapeutics, 2020-11, Vol.108 (5), p.921-923

2020

Volltextzugriff (PDF)

Response to “Personalized Dosing = Approved Wide Dose Ranges + Dose Titration”

Clinical pharmacology and therapeutics, 2021-03, Vol.109 (3), p.568-568

2021

Volltextzugriff (PDF)

Do Nonparametric Measures of Extreme Equity Risk Change the Parametric Ordinal Ranking? Evidence from Asia

Risks (Basel), 2018-12, Vol.6 (4), p.121

2018

Volltextzugriff (PDF)

Dosing Recommendations for New Oral Anticoagulants--Reply

JAMA : the journal of the American Medical Association, 2015-06, Vol.313 (24), p.2496

Powell, J Robert

2015

Volltextzugriff (PDF)

Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006

Journal of clinical pharmacology, 2008-02, Vol.48 (2), p.146-156

2008

Volltextzugriff (PDF)

Factors affecting the growth of small privately‐owned financial planning businesses

Australian economic papers, 2022-12, Vol.61 (4), p.717-737

2022

Volltextzugriff (PDF)

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

The AAPS journal, 2005-10, Vol.7 (3), p.E503-E512

2005

Volltextzugriff (PDF)

A dataset on tail risk of commodities markets

Data in brief, 2017-12, Vol.15, p.58-62

2017

Volltextzugriff (PDF)

Forecasting corporate financial distress in the Southeast Asian countries: A market-based approach

Journal of Asian economics, 2021-06, Vol.74, p.101293, Article 101293

2021

Volltextzugriff (PDF)

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

Journal of clinical pharmacology, 2022-12, Vol.62 (12), p.1518-1527

2022

Volltextzugriff (PDF)

Economic cycles and downside commodities risk

Applied economics letters, 2018-02, Vol.25 (4), p.258-263

2018

Volltextzugriff (PDF)

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact

Clinical and translational science, 2017-11, Vol.10 (6), p.443-454

2017

Volltextzugriff (PDF)

Volatility Spillovers from Australia's major trading partners across the GFC

International review of economics & finance, 2017-01, Vol.47, p.159-175

2017

Volltextzugriff (PDF)

The long and short of commodity tails and their relationship to Asian equity markets

Journal of Asian economics, 2017-10, Vol.52, p.32-44

2017

Volltextzugriff (PDF)

1 – 25 von 2.232

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.942)
Mit Volltextzugriff
(1.769)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.396)
Life Sciences & Biomedicine
(1.163)
Humans
(822)
Female
(456)
Male
(439)
Biological And Medical Sciences
(379)
Medical Sciences
(284)
Adult
(274)
Middle Aged
(264)
Animals
(258)
Aged
(220)
Physical Sciences
(187)
Adolescent
(128)
Social Sciences
(128)
Surgery
(124)
General & Internal Medicine
(118)
Fundamental And Applied Biological Sciences. Psychology
(113)
Chemistry
(112)
Technology
(107)
Mice
(105)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

A proposal for scientific framework enabling specific population drug dosing recommendations

A comprehensive stability indicator for banks

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

Utility of Model‐Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS Workshop

Drug Dosing Recommendations for All Patients: A Roadmap for Change

Are new oral anticoagulant dosing recommendations optimal for all patients?

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial

Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients

A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19

Response to “Personalized Dosing = Approved Wide Dose Ranges + Dose Titration”

Do Nonparametric Measures of Extreme Equity Risk Change the Parametric Ordinal Ranking? Evidence from Asia

Dosing Recommendations for New Oral Anticoagulants--Reply

Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006

Factors affecting the growth of small privately‐owned financial planning businesses

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

A dataset on tail risk of commodities markets

Forecasting corporate financial distress in the Southeast Asian countries: A market-based approach

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

Economic cycles and downside commodities risk

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact

Volatility Spillovers from Australia's major trading partners across the GFC

The long and short of commodity tails and their relationship to Asian equity markets

Aktive Filter

Suchergebnisse filtern